Drug Rehabs Online

Ariad Pharmaceuticals Management Discusses Q3 2012 Results – Earnings Call …
Filed under: dual diagnosis treatment centers

Depending on the results of this interim analysis, it may allow us to file for regulatory approval of ponatinib in the newly diagnosed clinical indication approximately 6 months earlier than otherwise. Next, as we noted at our recent Analyst and …
Source

 

Curis' CEO Discusses Q3 2012 Results – Earnings Call Transcript
Filed under: dual diagnosis treatment centers

This first-in-class Hedgehog pathway inhibitor, received FDA approval during the first quarter of this year for the treatment of adults with a type of basal cell carcinoma or BCC that has – and this is the label that it received that has spread to …
Source

 

Dual Diagnosis Treatment Centers In South Carolina

dualdiagnosistreatmentcenters.net

 

Related Dual Diagnosis Treatment Centers Information…